HSP90-IN-11

上海金畔生物科技有限公司为生命科学和医药研发人员提供生物活性分子抑制剂、激动剂、特异性抑制剂、化合物库、重组蛋白,专注于信号通路和疾病研究领域。

HSP90-IN-11 

HSP90-IN-11 (Compound 12c) 是一种有效的 HSP90 抑制剂。 HSP90-IN-11 显示出与 AUY-922 (Luminespib) 相当的有效 HSP90α 抑制作用。HSP90-IN-11 在 CRC 和 NSCLC 细胞中显示出显着的抗增殖活性,在两位数 nM 范围内。HSP90-IN-11 导致 NSCLC 细胞中客户蛋白 EGFR 和 Akt 的快速降解。HSP90-IN-11 诱导亚 G1 期群体的显着积累。

HSP90-IN-11

HSP90-IN-11 Chemical Structure

规格 是否有货
100 mg   询价  
250 mg   询价  
500 mg   询价  

* Please select Quantity before adding items.

生物活性

HSP90-IN-11 (Compound 12c) is a potent inhibitor of HSP90. HSP90-IN-11 displays potent HSP90α inhibition comparable to AUY-922 (Luminespib). HSP90-IN-11 shows significant antiproliferative activity in CRC and NSCLC cells in a double digit nM range. HSP90-IN-11 leads to rapid degradation of client proteins EGFR and Akt in NSCLC cells. HSP90-IN-11 induces significant accumulation of a sub-G1 phase population[1].

分子量

511.54

Formula

C27H30FN3O6

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

参考文献
  • [1]. Wu WC, et al. Fluoropyrimidin-2,4-dihydroxy-5-isopropylbenzamides as antitumor agents against CRC and NSCLC cancer cells. Eur J Med Chem. 2020 Oct 1;203:112540.

所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务